BioLife Solutions, Inc. provided revenue guidance for 2022. Total revenue for 2022 is expected to range from $159.5 million to $171.0 million, reflecting year-over-year growth of 34% to 44% and organic growth of 28% to 39%. COVID-19 related revenue is expected to account for approximately 8% to 9% of total revenue.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
20.89 USD | -3.02% | -3.86% | +28.68% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+28.68% | 99Cr | |
-5.37% | 18TCr | |
-0.27% | 11TCr | |
-1.95% | 6.83TCr | |
-6.44% | 4.7TCr | |
+14.54% | 4.56TCr | |
+7.77% | 4.24TCr | |
+19.38% | 3.1TCr | |
+16.55% | 2.55TCr | |
-6.91% | 2.32TCr |
- Stock Market
- Equities
- BLFS Stock
- News BioLife Solutions, Inc.
- BioLife Solutions, Inc. Provides Revenue Guidance for 2022